Effects of Hormone Therapy on Oxidative Stress in Postmenopausal Women with Metabolic Syndrome.

It has been reported that the prevalence of MetS in postmenopausal women oscillates between 30% to 40% according to NCEP-ATP III criteria [ 17 , 18 , 19 ], which is quite significant because in the past decade this figure has increased and it is estimated that women with MetS had a high risk to cardiovascular diseases [ 20 ].

also in 5,695 other papers